A detailed history of Empowered Funds, LLC transactions in Innoviva, Inc. stock. As of the latest transaction made, Empowered Funds, LLC holds 95,964 shares of INVA stock, worth $1.71 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
95,964
Previous 269,086 64.34%
Holding current value
$1.71 Million
Previous $4.41 Million 58.03%
% of portfolio
0.03%
Previous 0.08%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$16.33 - $20.04 $2.83 Million - $3.47 Million
-173,122 Reduced 64.34%
95,964 $1.85 Million
Q2 2024

Jul 30, 2024

BUY
$14.4 - $16.4 $277,344 - $315,864
19,260 Added 7.71%
269,086 $4.41 Million
Q1 2024

May 06, 2024

BUY
$14.56 - $16.78 $578,192 - $666,350
39,711 Added 18.9%
249,826 $3.81 Million
Q3 2023

Nov 01, 2023

BUY
$12.37 - $13.89 $213,036 - $239,213
17,222 Added 8.93%
210,115 $2.73 Million
Q2 2023

Jul 27, 2023

BUY
$11.39 - $13.72 $2.2 Million - $2.65 Million
192,893 New
192,893 $2.46 Million

Others Institutions Holding INVA

About Innoviva, Inc.


  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.24B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Empowered Funds, LLC Portfolio

Follow Empowered Funds, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Empowered Funds, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Empowered Funds, LLC with notifications on news.